1YBottom 25% of the group
Rank 62 of 63 funds
Return −9.92%
1Y returns of 63 funds in the Health Care group, sorted from highest to lowest. This fund ranks 62No. 1 is SCBGENOME(E) +62.13%
ONE MEDICAL TECHNOLOGY FUND
Shows where this fund stands in its group. Not investment advice · Data as of 3 Nov 2026
ONE-MEDTECH invests through the master fund iShares U.S. Medical Devices ETF (IHI) 98.66%
This fundONE-MEDTECH
The fund that actually investsSingle listed class (ETF) · United StatesThis fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
Abbott Laboratories ABT17.53%
Intuitive Surgical ISRG14.72%Data as of 30 Sep 2026 · Top 6 shown, the rest grouped as Other · per the issuer's fact sheet · Country inferred from the name of a single-country fund
Over the past year it was in the bottom 25% of its group; over 3 years it returned +1.86% per year (Bottom 25% of the group)
No. 1 is SCBGENOME(E) +62.13%
Each bar is one fund in the AIMC Health Care group, sorted from highest to lowest return · Every share class is counted, and only funds with a full track record for the period are included · Calculated from NAV as of 3 Nov 2026
Past performance is not a guarantee of future results
| YTD | 1W | 2W | 1M | 3M | 6M | 1Y | 3Y | MAX |
|---|---|---|---|---|---|---|---|---|
| −11.71% | +3.32% | +3.74% | +11.39% | +3.40% | +8.98% | −9.92% | +5.67% | −19.49% |
Total return over each period, matching the NAV chart periods · Not annualised
| Year | Jan | Feb | Mar |
|---|
Largest drawdown in the selected period −36.01% Previous peak 7 Apr 2022 (NAV 10.7240) → Trough 11 May 2026 (NAV 6.8623) · Not back to the previous peak as of 3 Nov 2026
Currently −24.92% from the peak NAV of 10.7240 (7 Apr 2022)
Over 3 years, ONE-MEDTECH returned 0.10 per unit of volatility, ranking 35 of 37 funds · The highest is TBIOTECH (0.88)
กองทุนมีนโยบายลงทุนในหน่วยลงทุนของกองทุนต่างประเทศเพียงกองทุนเดียว (Master Fund) คือ กองทุน iShares U.S. Medical Devices ETF (กองทุนหลัก) โดยเฉลี่ยในรอบปีบัญชีไม่น้อยกว่าร้อยละ 80 ของมูลค่าทรัพย์สินสุทธิของกองทุน ซึ่งกองทุนหลักเป็นกองทุนประเภท Exchange Traded Fund (ETF) บริหารจัดการโดย BlackRock… Its largest holdings are ABBOTT LABORATORIES 17.77% · INTUITIVE SURGICAL INC 14.92% · MEDTRONIC PLC 11.47% (fact sheet 30 Sep 2026)
Risk level 7 of 8 (High risk). Since 24 Jan 2022, its NAV has fallen as much as −36.01% from its peak.
Actual total expense ratio (TER) 1.90% a year, against a ceiling of 5.28%. Management fee 1.61%. Front-end fee 1.50%. Back-end fee 0.00%. (Fact sheet 31 Aug 2026)
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
Minimum first purchase 1,000 THB, subsequent purchases 1,000 THB. Buy orders accepted until 15:30, sell orders until 15:30, and redemption proceeds are paid T+4
Hedged at the manager's discretion. As of 30 Sep 2026, 87.11% of the value of its foreign investments was hedged
Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
Medtronic MDT
IDEXX IDXX4.51%
DexCom DXCM4.49%
Edwards Lifesciences EW4.46%
Stryker SYK4.45%
Becton Dickinson & BDX4.43%
ResMed RMD4.40%
Boston Scientific BSX4.32%Hospitals, medicines and medical equipment
Intuitive Surgical ISRGHospitals, medicines and medical equipment
Medtronic MDTHospitals, medicines and medical equipment
IDEXX IDXXMakes diagnostic analysers and test kits for veterinary clinics, as well as water quality test kits
DexCom DXCMStryker SYKHospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
ResMed RMDHospitals, medicines and medical equipment
Based on the master fund's share of this fund's value (98.66% as of 30 Sep 2026) × each stock's weight in the master fund · stocks as of 22 Oct 2026 · Illustrations are for explanation only, not individual stock recommendations
No. 1 is SCBGENOME(E) +21.97% per year
| Apr |
|---|
| May |
|---|
| Jun |
|---|
| Jul |
|---|
| Aug |
|---|
| Sep |
|---|
| Oct |
|---|
| Nov |
|---|
| Dec |
|---|
| Full year |
|---|
| 2026 | −4.2 | −0.1 | −11.1 | −4.8 | −4.5 | +1.1 | +5.7 | +4.2 | −6.7 | +6.3 | +3.3 | · | −11.7* |
| 2025 | +8.6 | −0.1 | −5.8 | −1.1 | +2.9 | +0.7 | −4.9 | +3.7 | −3.7 | −0.1 | +6.5 | −3.3 | +2.4 |
| 2024 | +3.4 | +1.8 | +3.1 | −6.4 | +0.4 | +0.6 | −2.8 | +5.7 | −0.4 | −1.2 | +4.6 | −4.6 | +3.6 |
| 2023 | +1.8 | −3.6 | +3.1 | +4.6 | −7.0 | +6.6 | −1.5 | −6.7 | −7.4 | −7.0 | +10.1 | +6.7 | −2.5 |
| 2022 | +1.6 | +0.0 | +3.3 | −9.6 | −1.1 | −7.5 | +7.0 | −6.4 | −6.7 | +6.2 | +4.0 | −1.6 | −11.8 |